Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Bonzano

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|May 5, 2019
ERK: A Key Player in the Pathophysiology of Cardiac HypertrophySimona Gallo, Annapia Vitacolonna, Alessandro Bonzano, et al.
Critical Reviews in Oncology/Hematology|March 18, 2018
Fluoropyrimidine-induced cardiotoxicityIlaria Depetris, Donatella Marino, Alessandro Bonzano, et al.
International Journal of Molecular Sciences|July 30, 2020
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3Simona Gallo, Martina Spilinga, Elena Casanova, et al.
Acta Haematologica|September 26, 2019
Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case ReportEleonora Ghisoni, Laura Marandino, Pasquale Lombardi, et al.
Future Oncology (London, England)|January 11, 2018
Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluationVeronica Prati, Fiorella Ruatta, Caterina Aversa, et al.
Cancers|February 7, 2020
Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective StudyElena Geuna, Pasquale Lombardi, Rossella Martinello, et al.
British Journal of Pharmacology|March 6, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitroSimona Gallo, Martina Spilinga, Raffaella Albano, et al.
The Breast Journal|April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidityRossella Martinello, Paolo Becco, Patrizia Vici, et al.
Journal of the American College of Cardiology|May 3, 2002
Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillationEmanuele Antonielli, Alfredo Pizzuti, Attila Pálinkás, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|March 7, 2009
[Management of heart failure in Piedmont Region]Nicolò Montali, Marco Bobbio, Enrico Cerrato, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|May 5, 2019
ERK: A Key Player in the Pathophysiology of Cardiac HypertrophySimona Gallo, Annapia Vitacolonna, Alessandro Bonzano, et al.
Critical Reviews in Oncology/Hematology|March 18, 2018
Fluoropyrimidine-induced cardiotoxicityIlaria Depetris, Donatella Marino, Alessandro Bonzano, et al.
International Journal of Molecular Sciences|July 30, 2020
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3Simona Gallo, Martina Spilinga, Elena Casanova, et al.
Acta Haematologica|September 26, 2019
Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case ReportEleonora Ghisoni, Laura Marandino, Pasquale Lombardi, et al.
Future Oncology (London, England)|January 11, 2018
Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluationVeronica Prati, Fiorella Ruatta, Caterina Aversa, et al.
Cancers|February 7, 2020
Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective StudyElena Geuna, Pasquale Lombardi, Rossella Martinello, et al.
British Journal of Pharmacology|March 6, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitroSimona Gallo, Martina Spilinga, Raffaella Albano, et al.
The Breast Journal|April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidityRossella Martinello, Paolo Becco, Patrizia Vici, et al.
Journal of the American College of Cardiology|May 3, 2002
Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillationEmanuele Antonielli, Alfredo Pizzuti, Attila Pálinkás, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|March 7, 2009
[Management of heart failure in Piedmont Region]Nicolò Montali, Marco Bobbio, Enrico Cerrato, et al.
Pageof 2